The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores
Open accessAbstract
Background & Aims It is unclear if hepatocellular carcinoma (HCC) risk declines over time after hepatitis C virus (HCV) eradication. We analyzed changes in HCC annual incidence over time following HCV eradication and identified dynamic markers of HCC risk. Methods We identified 48,135 patients who initiated HCV antiviral treatment from 2000 through 2015 and achieved a sustained virologic response (SVR) in the Veterans Health Administration (29,033 treated with direct-acting antiviral (DAA) agents and 19,102 treated with interferon-based regimens). Patients were followed after treatment until February 14, 2019 (average 5.4 years), during which 1509 incident HCCs were identified. Results Among patients with cirrhosis before treatment with DAAs (n=9784), those with pre-SVR fibrosis-4 (FIB-4) scores ≥3.25 had a higher annual incidence of HCC (3.66%/year) than those with FIB-4 scores <3.25 (1.16%/year) (adjusted hazard ratio, 2.14; 95% CI, 1.66–2.75). In DAA-treated patients with cirrhosis and FIB-4 scores ≥3.25, annual HCC risk decreased from 3.8%/year in the first year after SVR to 2.4%/year by the fourth year (P=.01). In interferon-treated patients with FIB-4 scores ≥3.25, annual HCC risk remained above 2%/year, even 10 years after SVR. A decrease in FIB-4 scores from ≥3.25 pre-SVR to <3.25 post-SVR was associated with an approximately 50% lower risk of HCC, but the absolute annual risk remained above 2%/year. Patients without cirrhosis before treatment (n=38,351) had a low risk of HCC, except for those with pre-SVR FIB-4 scores ≥3.25 (HCC risk 1.22%/year) and post-SVR FIB-4 scores≥3.25 (HCC risk 2.39%/year)—risk remained high for many years after SVR. Conclusions Patients with cirrhosis before an SVR to treatment for HCV infection continue to have a high risk for HCC (>2%/year) for many years, even if their FIB-4 score decreases, and should continue surveillance. Patients without cirrhosis but with FIB-4 scores ≥3.25 have a high enough risk to merit HCC surveillance, especially if FIB-4 remains ≥3.25 post-SVR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Bush, K. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1789 · Cited by 6,196
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Kanwal, F., Kramer, J., Asch, S. M., Chayanupatkul, M., Cao, Y., & El-Serag, H. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.012 · Cited by 931
Morgan, R. L., Baack, B., Smith, B. D., Yartel, A., Pitasi, M., & Falck-Ytter, Y. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 829
Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease
Kanwal, F., Kramer, J. R., Mapakshi, S., Natarajan, Y., Chayanupatkul, M., Richardson, P. A., Li, L., Desiderio, R., Thrift, A. P., Asch, S. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.024 · Cited by 795
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., Heimbach, J. K., et al. (2019) · Clinical Liver Disease · doi:10.1002/cld.802 · Cited by 645
Ioannou, G. N., Green, P. K., & Berry, K. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.030 · Cited by 573
Self-citationBeste, L. A., Leipertz, S. L., Green, P. K., Dominitz, J. A., Ross, D., & Ioannou, G. N. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.056 · Cited by 459
Self-citationMiller, D. R., Safford, M. M., & Pogach, L. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.suppl_2.b10 · Cited by 425
Vergniol, J., Foucher, J., Terrebonne, E., Bernard, P., le Bail, B., Merrouche, W., Couzigou, P., & de Ledinghen, V. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.058 · Cited by 415
El‐Serag, H. B., Kanwal, F., Richardson, P., & Kramer, J. (2016) · Hepatology · doi:10.1002/hep.28535 · Cited by 411
Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Kanwal, F., Hoang, T., Kramer, J. R., Asch, S. M., Goetz, M. B., Zeringue, A., Richardson, P., & El–Serag, H. B. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.032 · Cited by 395
Incidence and Predictors of Hepatocellular Carcinoma in Patients With Cirrhosis
Ioannou, G. N., Splan, M. F., Weiss, N. S., McDonald, G. B., Beretta, L., & Lee, S. P. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.02.039 · Cited by 363
Self-citationDavila, J. A., Henderson, L., Kramer, J. R., Kanwal, F., Richardson, P. A., Duan, Z., & El-Serag, H. B. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-2-201101180-00006 · Cited by 299
Implementation of evidence-based alcohol screening in the Veterans Health Administration.
Bradley, K. A., Williams, E. C., Achtmeyer, C. E., Volpp, B. D., Collins, B. J., & Kivlahan, D. R. (2006) · PubMed · Cited by 273
Singal, A. K., Singh, A., Jaganmohan, S., Guturu, P., Mummadi, R., Kuo, Y., & Sood, G. K. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.10.026 · Cited by 229
Self-citationPredictors of response of U.S. veterans to treatment for the hepatitis C virus
Backus, L. I., Boothroyd, D. B., Phillips, B. R., & Mole, L. A. (2007) · Hepatology · doi:10.1002/hep.21662 · Cited by 225
Ioannou, G. N., Beste, L. A., Chang, M. F., Green, P. K., Lowy, E., Tsui, J. I., Su, F., & Berry, K. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.049 · Cited by 215
Self-citationFailure Rates in the Hepatocellular Carcinoma Surveillance Process
Singal, A. G., Yopp, A. C., Gupta, S., Skinner, C. S., Halm, E. A., Okolo, E., Nehra, M., Lee, W. M., Marrero, J. A., & Tiro, J. A. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0046 · Cited by 208
Self-citationIoannou, G. N., Bryson, C. L., Weiss, N. S., Miller, R., Scott, J. D., & Boyko, E. J. (2013) · Hepatology · doi:10.1002/hep.25800 · Cited by 206
Self-citationEl-Serag, H. B., Kanwal, F., Davila, J. A., Kramer, J., & Richardson, P. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.045 · Cited by 181
Ioannou, G. N., Green, P. K., Beste, L. A., Mun, E. J., Kerr, K. F., & Berry, K. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.07.024 · Cited by 166
Self-citationImprovement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus
Hum, J., Jou, J. H., Green, P. K., Berry, K., Lundblad, J., Hettinger, B. D., Chang, M., & Ioannou, G. N. (2017) · Diabetes Care · doi:10.2337/dc17-0485 · Cited by 160
Self-citationEstimating risk of alcohol dependence using alcohol screening scores
Rubinsky, A. D., Kivlahan, D. R., Volk, R. J., Maynard, C. C., & Bradley, K. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.11.009 · Cited by 144
Beste, L. A., Green, P. K., Berry, K., Kogut, M. J., Allison, S. K., & Ioannou, G. N. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.027 · Cited by 142
Self-citationZangneh, H. F., Wong, W. W. L., Sander, B., Bell, C. M., Mumtaz, K., Kowgier, M. E., van der Meer, A. J., Cleary, S. P., Janssen, H. L. A., Chan, K., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.12.018 · Cited by 127
Self-citationIoannou, G. N., Green, P. K., Lowy, E., Mun, E. J., & Berry, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204412 · Cited by 117
Self-citationUtilization of Screening for Hepatocellular Carcinoma in the United States
Davila, J. A., Weston, A., Smalley, W. E., & El‐Serag, H. B. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3180381560 · Cited by 113
Zou, H., Yang, X., Li, Q., Zhou, Q.-X., Xiong, L., & Wen, Y. (2018) · Digestive Diseases · doi:10.1159/000486590 · Cited by 87
Kramer, J. R., Kanwal, F., Richardson, P. A., Giordano, T. P., Petersen, L. A., & El‐Serag, H. B. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.430 · Cited by 75
Ogasawara, N., Kobayashi, M., Akuta, N., Kominami, Y., Fujiyama, S., Kawamura, Y., Sezaki, H., Hosaka, T., Suzuki, F., Saitoh, S., et al. (2017) · Journal of Medical Virology · doi:10.1002/jmv.24950 · Cited by 70
Tsui, J. I., Williams, E. C., Green, P. K., Berry, K., Su, F., & Ioannou, G. N. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.021 · Cited by 69
Self-citationParadis, V., Dargère, D., Bonvoust, F., Rubbia‐Brandt, L., Bâ, N., Bioulac‐Sage, P., & Bédossa, P. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780165 · Cited by 55
Moon, A. M., Green, P. K., Berry, K., & Ioannou, G. N. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14021 · Cited by 52
Self-citationBeste, L. A., Ioannou, G. N., Larson, M. F., Chapko, M. K., & Dominitz, J. A. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.07.012 · Cited by 47
Self-citationMoon, A. M., Dominitz, J. A., Ioannou, G. N., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.040 · Cited by 46
Self-citationWilliams, E. C., Rubinsky, A. D., Lapham, G. T., Chavez, L. J., Rittmueller, S. E., Hawkins, E. J., Grossbard, J. R., Kivlahan, D. R., & Bradley, K. A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.11.016 · Cited by 45
White, D. L., Richardson, P., Tayoub, N., Davila, J. A., Kanwal, F., & El‐Serag, H. B. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.10.004 · Cited by 41
For Whom is Hepatocellular Carcinoma Surveillance After Sustained Virologic Response Cost-Effective?
Singal, A. G., & Ioannou, G. N. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.02.020 · Cited by 7
Self-citation
Cited by
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Self-citationAASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Singal, A. G., Llovet, J. M., Yarchoan, M., Mehta, N., Heimbach, J. K., Dawson, L. A., Jou, J. H., Kulik, L. M., Agopian, V. G., Marrero, J. A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000466 · Cited by 2,052
“[52] HCC incidence is significantly lower in post-SVR patients without cirrhosis, and surveillance is not cost-effective or recommended in this population.”
Self-citationEASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Singal, A. G., Lampertico, P., & Nahon, P. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.025 · Cited by 1,102
Self-citationSingal, A. G., Kanwal, F., & Llovet, J. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00825-3 · Cited by 951
Self-citation
Metadata
- Authors
- Ioannou, G. N., Beste, L. A., Green, P. K., Singal, A. G., Tapper, E. B., Waljee, A. K., Sterling, R. K., Feld, J. J., Kaplan, D. E., Taddei, T. H., & Berry, K.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 157
- Issue
- 5
- Pages
- 1264-1278.e4
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2965258952
- Cited by
- 401
- References
- 40
- FWCI
- 28.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.